Medical/Pharmaceuticals APAC News & Press Release Distribution

Medical/Pharmaceuticals

All
Global

Veritas Genetic participates in a groundbreaking study highlighting the importance of polygenic risk scores in the clinical management of breast cancer patients

* The study, conducted in collaboration with the Department of Biomedicine and Prevention at the University of Rome Tor Vergata and Tor Vergata University Hospital, underscores the relevance of polygenic risk scores (PRS) in risk stratification for patients with a genetic predisposition to brea...

2024-10-03 14:00 1734

CNN's 'Tomorrow Transformed' explores how the future of healthcare is connecting lives

HONG KONG, Oct. 3, 2024 /PRNewswire/ -- Since the dawn of healthcare, technology has been drastically improving medical systems and services to help us live longer and better lives. In this special half-hour episode of'Tomorrow Transformed', connections, partnerships, and collaborations in the wo...

2024-10-03 12:16 2278

CNN's 'Tomorrow Transformed' explores how the future of healthcare is connecting lives

Hetero Signs Voluntary Licensing Agreement with Gilead to Transform Global HIV response, Expanding Access to Groundbreaking Lenacapavir to 120 high-incidence countries

- Non-exclusive voluntary license agreement enables the manufacture and distribution of lenacapavir for HIV prevention and treatment of heavily treatment-experienced patients with multi drug-resistant HIV HYDERABAD, India, Oct. 2, 2024 /PRNewswire/ -- Hetero, India's leading pharmaceutical comp...

2024-10-02 22:53 2506

Australia takes centre stage as a cure for Rett Syndrome draws closer

GOLD COAST, Australia, Oct. 2, 2024 /PRNewswire/ -- Australian researcher Associate ProfessorWendy Gold, a world leader in Rett Syndrome research from the University of Sydney, joins international colleagues and Rett families on theGold Coast today to present the l...

2024-10-02 05:48 1811

Precision Medicine Group Welcomes Margaret Keegan as CEO

-- Founding CEO Mark Clein named Executive Chairman; Mr. Clein and co-founder Ethan Leder to continue as Board Directors -- BETHESDA, Md., Oct. 1, 2024 /PRNewswire/ -- Precision Medicine Group (Precision), a leading next-generation provider of drug development and commercialization services, to...

2024-10-01 20:49 1344

OPTEL and Worximity Join Forces to Boost Line Performance with Real-Time OEE Solutions

QUÉBEC CITY, Oct. 1, 2024 /PRNewswire/ -- OPTEL, a global leader in traceability and vision systems, and Worximity, a leading provider of OEE and real-time production monitoring, are partnering to help manufacturers boost operational efficiency.

2024-10-01 19:00 1076

OPTEL and Worximity Join Forces to Boost Line Performance with Real-Time OEE Solutions

Responding to spine surgeons' educational needs, AO Spine rolls out new competency-based curriculum courses in 2025

DAVOS, Switzerland, Oct. 1, 2024 /PRNewswire/ -- With a 20-plus-year legacy as the world's premier education provider in spine surgery, AO Spine —a clinical division of the AO —continues to revolutionize surgeon education with it...

2024-10-01 18:00 1449

Responding to spine surgeons' educational needs, AO Spine rolls out new competency-based curriculum courses in 2025

Frost & Sullivan co-published Recombinant Type III Triple-Helix Collagen Whitepaper with Everon Healthcare

SHANGHAI, Oct. 1, 2024 /PRNewswire/ -- Frost & Sullivan and Everon Healthcare have conducted extensive investigation across the recombinant collagen Industry and co-published the "Recombinant Type III Triple-Helix Collagen Whitepaper" on Sep. 29th, 2024, which aims to analyze the latest research a...

2024-10-01 17:28 1840

TraceLink Releases Amadeus, the First Generative AI Assistant for Accelerating the Digitalization of Supply Networks on the Opus Platform

Trained on a rich set of information from a unified content repository, Opus Orchestration Architects, Solution Designers, Network Administrators, and those simply interested in learning more about TraceLink's solutions are empowered with information in seconds BOSTON, Oct. 1, 2024 /PRNewswire/ ...

2024-10-01 16:00 1369

Great Place To Work® Australia and New Zealand names 15 Best Workplaces in Healthcare, Biopharma & Social Assistance in 2024

SYDNEY, Oct. 1, 2024 /PRNewswire/ -- Great Place To Work® ANZ, the global authority on workplace culture today announces theirinaugural 15 Best Workplaces™ in Healthcare, Social Assistance and BioPharma in 2024. The companies are announced across two lists: Best Workplaces in Biotechnology a...

2024-10-01 07:00 8042

Social support becomes lifeline for health amid financial strain

* Study reveals health and vitality is closely linked to mental, social, and physical health. * Financial well-being remains the weakest aspect of well-being, with finance-related concerns as top stressors * High vitality leads to better health management and stronger support networks HONG ...

2024-10-01 00:01 2764

Argon Medical Announces the Expansion of Liver Management Portfolio with Two New Product Introductions

PLANO, Texas, Sept. 30, 2024 /PRNewswire/ -- Argon Medical Devices, a leading provider of medical device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology procedures, announced the launch of the Intara™ Introducer Sheath and the TLAB® Transvenous Li...

2024-09-30 21:52 1405

GenEditBio Secures Strategic Investment from Gobi Partners GBA to Accelerate Breakthrough Genome Editing Technologies

HONG KONG, Sept. 30, 2024 /PRNewswire/ -- GenEditBio Limited ("GenEditBio"), a biotech company co-founded by Prof. ZHENG Zongli from the CityUniversity of Hong Kong that focuses on precision genome editing to provide affordable "precision DNA surgery" for genetic diseases with unmet needs, is ple...

2024-09-30 19:36 1760

GenEditBio Secures Strategic Investment from Gobi Partners GBA to Accelerate Breakthrough Genome Editing Technologies

Alphamab Oncology and CSPC Achieved a Licensing Agreement on Anti-HER2 Bispecific ADC JSKN003 in Mainland China

SUZHOU, China, Sept. 30, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966 HK) announced that Jiangsu Alphamab Biopharmaceuticals Co., Ltd. ("Alphamab"), a wholly-owned subsidiary of Alphamab Oncology ("the Company"), entered into a licensing agreement (the "Licensing Agreement") on anti-H...

2024-09-30 10:35 3235

Herbalgy 25th Anniversary - Touch Cool- Peppermint Cooling to Soothe Various Pains Anytime, Anywhere

HONG KONG, Sept. 30, 2024 /PRNewswire/ -- Since its establishment in 1999, Herbalgy Pharmaceutical Ltd. has been dedicated to developing products that meet the diverse needs ofHong Kong people. In addition to the "Herbalgy" brand, they have launched two other brands, "Touch Cool" and "Tibet Red,"...

2024-09-30 09:30 1506

Herbalgy 25th Anniversary - Touch Cool- Peppermint Cooling to Soothe Various Pains Anytime, Anywhere

Multiple Study Results of Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) at 2024 CSCO Congress

CHENGDU, China, Sept. 29, 2024 /PRNewswire/ -- From September 25th to 29th, the 27th China Clinical Oncology Congress and the 2024 CSCO Annual Meeting were held inXiamen. Experts and scholars in the field of oncology from all over China gathered together to discuss the hotspots at the forefront o...

2024-09-29 11:52 2548

Multiple Study Results of Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) at 2024 CSCO Congress

Frost & Sullivan Released Report: "2024 Blue Book on Chinese Biopharmaceuticals Going Global: Current Status and Trends"

SHANGHAI, Sept. 28, 2024 /PRNewswire/ -- Frost & Sullivan released the "2024 Blue Book on Chinese Biopharmaceuticals Going Global: Current Status and Trends" which focus on the progress of Chinese biopharmaceuticals going global and analyzes the driving forces behind their accelerated global expa...

2024-09-28 09:11 3252

TraceLink Propels Organizations Toward DSCSA Compliance Ahead of the November 2024 Deadline

BOSTON, Sept. 27, 2024 /PRNewswire/ -- With the Drug Supply Chain Security Act (DSCSA) stabilization period ending onNovember 27, 2024, the TraceLink customer and trading partner community of healthcare and life sciences companies continues to demonstrate market leadership in demonstrating compli...

2024-09-27 22:00 1805

LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation

GAITHERSBURG, Md., Sept. 27, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for ...

2024-09-27 19:00 1490

Anbogen Announces Drug Supply Collaboration with BeiGene to Evaluate Combination Therapy in Colorectal Cancer

TAIPEI, Sept. 27, 2024 /PRNewswire/ -- Anbogen, a clinical-stage biotech company, today announced a drug supply collaboration to evaluate the combination of Anbogen's HDAC inhibitor, ABT-301, with BeiGene's anti-PD-1 antibody tislelizumab, in patients with mismatch repair–proficient (pMMR) or mi...

2024-09-27 16:00 1548

1 ... 9 10 111213 14 15 ... 396